Benjamin J. Ansell
- Surgery top 1%
- Endocrinology, Diabetes and Metabolism top 0.5%
- Cardiology and Cardiovascular Medicine top 2%
- Molecular Biology
- Cancer Research top 5%
- Co-authors
- Alan M. FogelmanGregg C. FonarowMohamad NavabSrinivasa T. ReddyInder M. SinghMehdi H. ShishehborGreg HoughSusan Hama
- Topics
- Lipoproteins and Cardiovascular Health (26 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (22 papers)Health Systems, Economic Evaluations, Quality of Life (6 papers)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Benjamin J. Ansell
32 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Surgery 1.9k
- Endocrinology, Diabetes and Metabolism 1.6k
- Cardiology and Cardiovascular Medicine 711
- Molecular Biology 613
- Cancer Research 560
Countries citing papers authored by Benjamin J. Ansell
This map shows the geographic impact of Benjamin J. Ansell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin J. Ansell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin J. Ansell more than expected).
Fields of papers citing papers by Benjamin J. Ansell
This network shows the impact of papers produced by Benjamin J. Ansell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin J. Ansell. The network helps show where Benjamin J. Ansell may publish in the future.
Co-authorship network of co-authors of Benjamin J. Ansell
This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin J. Ansell. A scholar is included among the top collaborators of Benjamin J. Ansell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin J. Ansell. Benjamin J. Ansell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Dysfunctional HDL and atherosclerotic cardiovascular diseasebreakdown → | 567 |
| 2 | 1 | |
| 3 | 16 | |
| 4 | 28 | |
| 5 | 350 | |
| 6 | 22 | |
| 7 | 157 | |
| 8 | 195 | |
| 9 | 31 | |
| 10 | 66 | |
| 11 | 232 | |
| 12 | 116 | |
| 13 | 12 | |
| 14 | Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDLbreakdown → | 546 |
| 15 | 42 | |
| 16 | 43 | |
| 17 | 6 | |
| 18 | 2 | |
| 19 | 30 | |
| 20 | 82 |
About Benjamin J. Ansell
Benjamin J. Ansell is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice and Clinical Biochemistry, having authored 33 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (26 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (22 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Clinical Biochemistry (443 citations) and Biochemistry (273 citations). Benjamin J. Ansell has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Alan M. Fogelman, Gregg C. Fonarow, Mohamad Navab, Srinivasa T. Reddy, Inder M. Singh, Mehdi H. Shishehbor, Greg Hough, Susan Hama, Naeimeh Kamranpour and Brian J. Van Lenten. Their work appears in journals such as New England Journal of Medicine, JAMA and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.